Pharma Focus Asia

Amgen Invests US$325 million to Construct New Plant in Central Ohio

Introduction:

Amgen plans to construct new biomanufacturing plant. The new plant will support the increasing demand for Amgen's medicines in the United States.

Features:

The new state-of-the-art manufacturing facility, enables to bring new innovative medicines for patients.

This cutting edge facility will be used by 400 ohioans for package medicines and benefit millions of people’s life those battling with serious illnesses. Moreover, environmental sustainability will be a major priority and it also ensures to maximise energy efficiency and waste reduction, plans to make operations carbon neutral over the next several years.

After the completion of the project, it will provide new job opportunities for technicians and engineers, along with quality assurance, quality control, administrative and management positions.

The construction of the new facility is expected to be fully operational by 2024.

Specifications:

NameAmgen
TypeNew Construction
BudgetUS$325 million
Year2024
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024